News
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 most profitable NASDAQ stocks to buy now. On June 9, Regeneron ...
Cemiplimab improved disease-free survival in patients with high-risk cutaneous squamous cell carcinoma (CSCC) and performed ...
Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...
AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.
Greater disease control and satisfaction as well as lower recurrence rates were associated with isotretinoin 20 mg vs 10 mg for seborrheic dermatitis.
4d
Sportschosun on MSNIdentifying Cells Mediating the Effect of Immunotherapy for Atopic Dermatitis...Specific regulatory ...Cells and processes that bring about the effect of immunotherapy on atopic dermatitis have been revealed. A research team led by Park Chang-wook, a dermatologist at Severance Hospital, Park Jung-won, ...
These are the first clinical study results for the drug in a large population of patients with darker skin tones ...
Nektar Therapeutics' REZPEG shows progress in treating atopic dermatitis & alopecia areata. Click here to find out why I rate ...
The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...
aDepartment of Pharmacy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, China bInnovation Center for Medical Basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results